NCT05038943View on ClinicalTrials.gov

Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

April 8, 2022

Study Completion Date

April 8, 2022

Conditions
Heart Transplant FailureDetermination of DeathOutcomes ResearchExtracorporeal Membrane Oxygenation
Interventions
DEVICE

Paragonix SherpaPak Cardiac Transport System

Transportation of cardiac allografts in a device maintaining constant optimal temperature to minimize freezing tissue injury

Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT05038943 - Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation | Biotech Hunter | Biotech Hunter